Unveiling Maternal-fetal BRAin-body Interactions in Pregnant WOmen Affected by Depression
A legfontosabb adatok
- Ki végzi
- Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- Hol
- Németország, Olaszország és Spanyolország3 helyszín, 3 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 720 fő, tervezett
- Kezdés
- 2026. ápr. 29.
- Várható befejezés
- 2028. jún.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoport
- A vizsgált kezelések
- Multimodal MRI and EEG-ECG/PPG recordings
- Biological sampling
- Clinical and neurodevelopmental assessments
- A regiszteradat frissítve
- 2026. november 12.
Ki vehet részt
- Életkor
- Legfeljebb 45 év
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Részt vehetnek
A regiszter feltételei, szó szerint
Mind a 28 feltétel megnézéseKevesebb
Ki vehet részt
- Pregnant women with major depressive disorder (Group 1):
- Signed informed consent and ability to understand and provide it
- Age between 18 and 45 years
- IQ > 70 (4 subtests of WAIS-IV: Vocabulary, Similarities, Block Design, Matrix Reasoning)
- Diagnosis of major depressive disorder according to the SCID-5-CV at screening (within 20 gestational weeks); Pregnant women without depression (Group 2):
- Signed informed consent and ability to understand and provide it
- Age between 18 and 45 years
- IQ > 70 (4 subtests of WAIS-IV: Vocabulary, Similarities, Block Design, Matrix Reasoning)
- No current or past psychiatric disorders (SCID-5-CV)
- No family history of psychiatric disorders (SCID-5-CV and FIGS); Placental tissue sampling (Milan only, Groups 1 and 2):
- Elective cesarean delivery
- Absence of labor; Newborns:
- Informed consent signed by both parents
- Full-term birth (gestational age at birth of 37 weeks or more)
Ki nem vehet részt
- Use of systemic corticosteroids
- Severe prior obstetric conditions
- History of head trauma with loss of consciousness
- Neurological or degenerative disorders
- Comorbid psychiatric disorders
- History of perinatal alcohol or drug abuse
- Infectious or autoimmune diseases
- Congenital, genetic or neurological disorders affecting the mother or the fetus
- Congenital, genetic or neurological disorder of the newborn
- Pregnant women (Groups 1 and 2):
- Twin pregnancy
- Pregnancy resulting from assisted reproductive technology with egg donation
- Body mass index (BMI) > 30
- Absolute or relative contraindications to MRI; Newborns:
Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.
3 országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
The goal of this study is to learn how depression during pregnancy is linked to changes in the brain and body of the mother and to the development of the baby, in pregnant women with major depressive disorder (MDD) and pregnant women without depression.
A teljes eredeti leírásKevesebb
The main questions it aims to answer are:
* How common is major depressive disorder during pregnancy in a European multi-site cohort? * Do pregnant women with MDD show differences in hippocampal volume compared with pregnant women without depression? * Do maternal blood, placenta, cord blood, brain imaging and heart activity measures, and the brain and development of the babies, differ between the two groups?
Pregnant women will be screened within the 20th week of pregnancy and assigned to the MDD group or to the control group based on a structured clinical interview. They will not receive any study drug: women with depression will receive the usual care recommended by clinical guidelines.
Participants will:
* Have clinical, psychiatric and psychological assessments (interviews and questionnaires) at screening, at 22, 26 and 32 weeks of pregnancy, at birth, and at 1 and 6 months after birth * Have a brain MRI with simultaneous EEG-ECG or photoplethysmography (PPG) at about 22 weeks of pregnancy * Have a fetal MRI by 22 weeks and fetal ultrasound scans at 22, 26 and 32 weeks * Give blood samples at 22, 26 and 32 weeks of pregnancy, and a cord blood sample at birth (placenta samples in a subgroup at the Milan center only)
Their newborns will have a neurological and visual examination, a brain MRI and an EEG-ECG or PPG recording after birth, and a developmental assessment (Bayley Scales) at 6 months.
A vizsgálat 2 csoportja
- Pregnant Women With Major Depressive Disorder (Group 1)Egyéb csoport
Pregnant women aged 18-45 years diagnosed with major depressive disorder (SCID-5-CV) at screening (within 20 gestational weeks), followed until 6 months postpartum, and their newborns. Participants receive standard clinical care for depression, which may include SSRI antidepressants; no study drug is administered.
Kezelés: Multimodal MRI and EEG-ECG/PPG recordings, Biological sampling és Clinical and neurodevelopmental assessments
- Pregnant Women Without Depression (Group 2)Egyéb csoport
Pregnant women aged 18-45 years without current or past psychiatric disorders and without family history of psychiatric disorders (SCID-5-CV and FIGS), followed until 6 months postpartum, and their newborns.
Kezelés: Multimodal MRI and EEG-ECG/PPG recordings, Biological sampling és Clinical and neurodevelopmental assessments
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- A regiszteradat frissítve
- 2026. november 12.